FDMT - 4D Molecular Therapeutics reports Q1 results
2024-05-09 17:49:01 ET
More on 4D Molecular Therapeutics
- 4D Molecular Therapeutics: Catalysts With Pioneering Gene Therapy With Directed Evolution
- 4D Molecular Therapeutics new overweight at Barclays on genetic medicine platform
- 4D Molecular slips after regulatory update on lead asset
- Seeking Alpha’s Quant Rating on 4D Molecular Therapeutics
- Historical earnings data for 4D Molecular Therapeutics